高雄醫學大學圖書館 |

語系/ Language: 繁體中文

登入

回首頁

Novel therapeutics for rare lymphomas

SpringerLink (Online service)

Novel therapeutics for rare lymphomas

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Novel therapeutics for rare lymphomas/ edited by Christopher Dittus.
其他作者:	Dittus, Christopher.
出版者:	Cham :Springer International Publishing : : 2020.,
面頁冊數:	x, 253 p. :ill. (some col.), digital ; : 24 cm.;
提要註:	This comprehensive volume reviews the clinical presentation, diagnosis, and treatment approach to rare lymphomas. There is particular emphasis placed on new diagnostic approaches, novel chemotherapy combinations, and treatment modalities with novel therapeutics. It highlights research advances in a group of diseases that are often overlooked, and serves as a single repository of information on the most recent advances in targeted small molecule inhibitors, monoclonal antibodies, immunotherapy, and CAR-T therapy as they pertain to rare types of lymphoma. Written for practicing oncologists, hematologists, fellows, and residents, Novel Therapeutics for Rare Lymphomas covers rare subtypes of lymphoma, including indolent and aggressive T-cell lymphomas and B-cell lymphomas.
Contained By:	Springer eBooks
標題:	Hematology. -
電子資源:	https://doi.org/10.1007/978-3-030-25610-4
ISBN:	9783030256104

Novel therapeutics for rare lymphomas
Novel therapeutics for rare lymphomas[electronic resource] /edited by Christopher Dittus. - Cham :Springer International Publishing :2020. - x, 253 p. :ill. (some col.), digital ;24 cm.

The Hematopathology and Diagnostic Challenges of Rare Lymphomas -- Novel Therapeutics in the Management of Waldenstrom Macroglobulinemia -- Immunotherapy in Hodgkin Lymphoma and other CD30+ Lymphomas -- Chronic Lymphocytic Leukemia with Alterations in TP53 -- Mantel Cell Lymphoma -- Current and Emerging Treatment Strategies from Primary Mediastinal B-Cell Lymphoma -- Plasmablastic Lymphoma and Primary Effusion Lymphoma -- Novel Agents in Primary Central Nervous System Lymphoma -- Adult T-Cell Leukemia/Lymphoma -- Extranodal NK/T-Cell Lymphoma -- Anaplastic Large Cell Lymphoma -- Enteropathy-Associated T-Cell Lymphomas -- Hepatosplenic T-Cell Lymphoma -- Cutaneous T-Cell Lymphoma: Mycosis Fungoides and Sezary Syndrom.

This comprehensive volume reviews the clinical presentation, diagnosis, and treatment approach to rare lymphomas. There is particular emphasis placed on new diagnostic approaches, novel chemotherapy combinations, and treatment modalities with novel therapeutics. It highlights research advances in a group of diseases that are often overlooked, and serves as a single repository of information on the most recent advances in targeted small molecule inhibitors, monoclonal antibodies, immunotherapy, and CAR-T therapy as they pertain to rare types of lymphoma. Written for practicing oncologists, hematologists, fellows, and residents, Novel Therapeutics for Rare Lymphomas covers rare subtypes of lymphoma, including indolent and aggressive T-cell lymphomas and B-cell lymphomas.

ISBN: 9783030256104

Standard No.: 10.1007/978-3-030-25610-4doiSubjects--Topical Terms:

240858
Hematology.

LC Class. No.: RC280.L9

Dewey Class. No.: 616.99446

Novel therapeutics for rare lymphomas
LDR:02457nam a2200325 a 4500 001 338335
003 DE-He213
005 20200304115441.0
006 m d
007 cr nn 008maaau
008 210622s2020 gw s 0 eng d
020 $a 9783030256104 $q (electronic bk.)
020 $a 9783030256098 $q (paper)
024 7 $a 10.1007/978-3-030-25610-4 $2 doi
035 $a 978-3-030-25610-4
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.L9
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.99446 $2 23
090 $a RC280.L9 $b N937 2020
245 0 0 $a Novel therapeutics for rare lymphomas $h [electronic resource] / $c edited by Christopher Dittus.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2020.
300 $a x, 253 p. : $b ill. (some col.), digital ; $c 24 cm.
505 0 $a The Hematopathology and Diagnostic Challenges of Rare Lymphomas -- Novel Therapeutics in the Management of Waldenstrom Macroglobulinemia -- Immunotherapy in Hodgkin Lymphoma and other CD30+ Lymphomas -- Chronic Lymphocytic Leukemia with Alterations in TP53 -- Mantel Cell Lymphoma -- Current and Emerging Treatment Strategies from Primary Mediastinal B-Cell Lymphoma -- Plasmablastic Lymphoma and Primary Effusion Lymphoma -- Novel Agents in Primary Central Nervous System Lymphoma -- Adult T-Cell Leukemia/Lymphoma -- Extranodal NK/T-Cell Lymphoma -- Anaplastic Large Cell Lymphoma -- Enteropathy-Associated T-Cell Lymphomas -- Hepatosplenic T-Cell Lymphoma -- Cutaneous T-Cell Lymphoma: Mycosis Fungoides and Sezary Syndrom.
520 $a This comprehensive volume reviews the clinical presentation, diagnosis, and treatment approach to rare lymphomas. There is particular emphasis placed on new diagnostic approaches, novel chemotherapy combinations, and treatment modalities with novel therapeutics. It highlights research advances in a group of diseases that are often overlooked, and serves as a single repository of information on the most recent advances in targeted small molecule inhibitors, monoclonal antibodies, immunotherapy, and CAR-T therapy as they pertain to rare types of lymphoma. Written for practicing oncologists, hematologists, fellows, and residents, Novel Therapeutics for Rare Lymphomas covers rare subtypes of lymphoma, including indolent and aggressive T-cell lymphomas and B-cell lymphomas.
650 2 4 $2 96060 $a Hematology. $3 240858
650 1 4 $2 96060 $a Oncology. $3 273823
650 0 $a Lymphomas $x Treatment. $3 310260
700 1 $a Dittus, Christopher. $3 466299
710 2 $2 97100 $a SpringerLink (Online service) $3 255133
773 0 $t Springer eBooks
856 4 0 $u https://doi.org/10.1007/978-3-030-25610-4
950 $a Medicine (Springer-11650)

筆 0 讀者評論

多媒體

評論

新增評論分享你的心得，請勿在此評論區張貼涉及人身攻擊、情緒謾罵、或內容涉及非法的不當言論，館方有權利刪除任何違反評論規則之發言，情節嚴重者一律停權，以維護所有讀者的自由言論空間。

Export

取書館別